https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214665
Jaguar Health FY21 Sales $15.719M, Down 23.4% YoY
Jaguar Health (NASDAQ:JAGX) will report on Q4 2021.
Related Posts
Stock Of This Company That Rivals Microsoft’s GitHub Jumped 35% On Nasdaq Debut Today
On its debut on the Nasdaq, GitLab Inc (NASDAQ: GTLB), a competitor of the Microsoft Corporation’s (NASDAQ: MSFT) GitHub, saw its stock shoot up nearly 35%.
Morgan Stanley Maintains Equal-Weight on DTE Energy, Lowers Price Target to $142
Morgan Stanley analyst Stephen Byrd maintains DTE Energy (NYSE:DTE) with a Equal-Weight and lowers the price target from $148 to $142.
Goldman Sachs Maintains Sell on Roblox, Raises Price Target to $21
Goldman Sachs analyst Kevin Kumar maintains Roblox (NYSE:RBLX) with a Sell and raises the price target from $19 to $21.